1Mussap M,Plebani M. Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci, 2004, 41: 467-550.
2Werle B, Sauckel K, Nathanson CM, et al. Cystatin C, E/M and F inhuman pleural fluids of patations with neuplastic and inflammatory lung disorders. Biol Chem, 2003, 384:281-287.
3Monastero R, Camarda C, Cefalu AB, et al. No association between the cystatin C gene polymorphisrn and Alzheimerr s disease: a case-control study in an Italian population. J Alzheimers Dis, 2005, 7:291-295.
4Tian J, Shi J, Mann DM. Cerebral amyloid angiopathy and dementia. Panminerva Med, 2004, 46:253-264.
5Dodel RC, Du Y, Depboylu C,et al. A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD. Neurol, 2002, 58:664-664.
6Souza DR, de Godoy MR, Hotta J, et al. Association of apolipoprotein E polymorphism in late-onset Alzheimer′s disease and vascular dementia in Brazilians. Braz J Med Biol Res, 2003, 36:919-923.
7Harris FM, Brecht WJ, Xu Q, et al. Carboxyl- terminal-truncated apolipoprotein E4 causes Alzheimer disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci USA, 2003, 100: 10 966-10 971.
